Growth Metrics

Jazz Pharmaceuticals (JAZZ) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.15%
Dec 31, 2025 -19.60%
Sep 30, 2025 36.73%
Jun 30, 2025 -4.79%
Mar 31, 2025 -3.55%
Dec 31, 2024 17.45%
Sep 30, 2024 5.48%
Jun 30, 2024 -7.79%
Mar 31, 2024 16.06%
Dec 31, 2023 -5.66%
Sep 30, 2023 -8.66%
Jun 30, 2023 9.02%
Mar 31, 2023 -8.46%
Dec 31, 2022 8.60%
Sep 30, 2022 5.58%
Jun 30, 2022 7.22%
Mar 31, 2022 -5.74%
Dec 31, 2021 -0.23%
Sep 30, 2021 10.54%
Jun 30, 2021 39.66%
Mar 31, 2021 9.88%
Dec 31, 2020 3.39%
Sep 30, 2020 -0.81%
Jun 30, 2020 6.81%
Mar 31, 2020 10.48%
Dec 31, 2019 -9.89%
Sep 30, 2019 1.75%
Jun 30, 2019 2.67%
Mar 31, 2019 3.10%
Dec 31, 2018 6.45%
Sep 30, 2018 -4.59%
Jun 30, 2018 8.27%
Mar 31, 2018 -11.05%
Dec 31, 2017 0.72%
Sep 30, 2017 -0.49%
Jun 30, 2017 8.20%
Mar 31, 2017 3.76%
Dec 31, 2016 -2.38%
Sep 30, 2016 -2.20%
Jun 30, 2016 5.17%
Mar 31, 2016 -0.55%
Dec 31, 2015 5.20%
Sep 30, 2015 -0.80%
Jun 30, 2015 11.92%
Mar 31, 2015 9.46%
Dec 31, 2014 4.21%
Sep 30, 2014 -1.62%
Jun 30, 2014 34.29%
Sep 30, 2013 58.61%
Jun 30, 2013 131.39%
Mar 31, 2013 11.48%
Dec 31, 2012 18.80%
Sep 30, 2012 25.75%
Jun 30, 2012 60.26%
Mar 31, 2012 -55.05%
Dec 31, 2011 128.48%
Sep 30, 2011 -6.44%
Jun 30, 2011 8.48%
Mar 31, 2011 39.91%
Dec 31, 2010 3.35%